StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.33−0.01 (-0.75%)

Close on Nov 18, 2026Market cap $65.46MP/E –Yield –

MediciNova revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MediciNova's revenue for the twelve months ending Jun 30, 2026 was $920.48K. For fiscal 2025 it was $409.66K, down 59.0% from the year before. The highest annual figure on record is $4.04M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$409.66K-59.0%
FY2023Dec 31, 2023$1.00M-75.2%
FY2021Dec 31, 2021$4.04M+123863.8%
FY2013Dec 31, 2013$3.26K-99.6%
FY2012Dec 31, 2012$802.58K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$458.44K+240.6%
Q1 FY2026Mar 31, 2026$186.98K–
Q4 FY2025Dec 31, 2025$151.74K-84.8%
Q3 FY2025Sep 30, 2025$123.32K–
Q2 FY2025Jun 30, 2025$134.60K+258.9%
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$1.00M-75.0%
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$37.50K–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$4.00M–

More MediciNova figures

See a number that looks wrong?